Roche Had A Positive Cancer Study — And Its Rival Flew 130% - Investor's Business Daily
#Cancer Study#Rival Flew#Investor Business#Positive Cancer#Business Daily
Life Science News
Latest updates from the biotech and pharma world
Roche pill notches win in early breast cancer - BioPharma Dive
#Roche pill#BioPharma Dive#pill notches#notches win#early breast
Roche's oral SERD notches second pivotal breast cancer win - FirstWord Pharma
#oral SERD#SERD notches#Roche oral#FirstWord Pharma#pivotal breast
OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results - Stocktwits
#Stock Doubles#Roche Cancer#Cancer Drug#Drug Trial#Trial Yields
Roche's oral SERD goes 2 for 2, hitting goal in phase 3 adjuvant breast cancer trial - Fierce Biotech
#Fierce Biotech#oral SERD#hitting goal#adjuvant breast#Roche oral
Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S. - PR Newswire
#Announces Exclusive#Exclusive Agreement#Expand Technology#Technology Collaboration#Commercialize Cancer
Roche touts early giredestrant success | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
#Clinical Trials#Oncology Pipeline#giredestrant success#Roche touts#touts early
Roche boosts Olema as breast cancer therapy succeeds in late-stage trial - Seeking Alpha
#Seeking Alpha#boosts Olema#Roche boosts#breast cancer#cancer therapy
New experimental drug could transform care for cancer patients - The Independent
#experimental drug#transform care#cancer patients#Independent#experimental
Roche Shares Rise After Breast-Cancer Pill Shows Positive Results in Trial - The Wall Street Journal
#Shares Rise#Pill Shows#Shows Positive#Positive Results#Wall Street
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? - simplywall.st
#Stock Jump#Reassess Roche#Drug Pipeline#Pipeline Developments#Stock
Roche reports positive Phase III data of giredestrant for breast cancer - Clinical Trials Arena
#Phase III#Clinical Trials#Trials Arena#positive Phase#III data
Roche oral drug shown to keep breast cancer at bay, boosting shares - Reuters
#boosting shares#Roche oral#oral drug#drug shown#breast cancer
Roche Gives Glimpse of Cancer Genomics Potential of New Axelios Sequencer - GenomeWeb
#Cancer Genomics#Genomics Potential#Axelios Sequencer#Sequencer GenomeWeb#GenomeWeb Roche
Obituary information for Kathleen M. Roche - Cartmell Davis Funeral Home
#Davis Funeral#Cartmell Davis#Funeral Home#Roche Cartmell#Obituary information
Ice Bears swap Finstrom for blue liner Roche - Knoxville Ice Bears
#Ice Bears#Knoxville Ice#swap Finstrom#Bears swap#Bears Ice
Roche’s fenebrutinib shows best-in-disease potential in MS - European Pharmaceutical Review
#European Pharmaceutical#Pharmaceutical Review#fenebrutinib shows#Review Roche#Pharmaceutical
Roche sizes up first BTK inhibitor approval on Phase III MS victory - Clinical Trials Arena
#Phase III#Clinical Trials#Trials Arena#BTK inhibitor#Roche sizes
Artificial Intelligence at Roche Diagnostics - Emerj Artificial Intelligence Research
#Artificial Intelligence#Intelligence Research#Roche Diagnostics#Emerj Artificial#Research Artificial
Roche reports phase 3 multiple sclerosis wins for BTK inhibitor, succeeding where rivals failed - Fierce Biotech
#BTK inhibitor#Fierce Biotech#reports phase#multiple sclerosis#Roche reports